Literature DB >> 10985757

Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients.

R C Baxter1, F H Hawker, C To, P M Stewart, S R Holman.   

Abstract

This study investigates the regulation of the insulin-like growth factors (IGFs) and their regulatory proteins in 14 critically ill patients during the 30-day period following admission to an intensive care unit (ICU). Levels of IGF-I, IGF-II, IGF binding protein-3 (IGFBP-3) and acid-labile subunit (ALS) were low on admission, and in the 8 patients whose serum IGF-I levels failed to increase over 30 days, levels of the other proteins also remained low, while IGFBP-3 proteolytic activity increased. Of these proteins, ALS correlated best with serum levels of nutritional indicators, particularly prealbumin. IGFBP-2 and IGFBP-6 levels tended to be high in critically ill patients, but showed little change over the 30-day period. In contrast, IGFBP-1 levels were high on admission, correlated with early changes in nitrogen balance, and fell rapidly during the first week. By demonstrating that the IGF-I response in ICU patients is related to changes in the IGF regulatory proteins, this study may be of value in planning therapeutic intervention using growth hormone or IGF-I.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10985757     DOI: 10.1016/s1096-6374(98)80298-0

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  9 in total

1.  Insulin-like growth factor-1 and delirium in critically ill mechanically ventilated patients: a preliminary investigation.

Authors:  A Morandi; M L Gunther; P P Pandharipande; J C Jackson; J L Thompson; A K Shintani; E W Ely; T D Girard
Journal:  Int Psychogeriatr       Date:  2011-02-04       Impact factor: 3.878

Review 2.  Biochemical investigations in diagnosis and follow up of acromegaly.

Authors:  Katharina Schilbach; Christian J Strasburger; Martin Bidlingmaier
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study.

Authors:  Stepani Bendel; Timo Koivisto; Olli-Pekka Ryynänen; Esko Ruokonen; Jarkko Romppanen; Vesa Kiviniemi; Ari Uusaro
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

4.  Insulin-like growth factor I (IGF-I) as a sensitive biomarker of catabolism in patients with gastrointestinal diseases.

Authors:  Olgica Nedić; Vesna Malenković; Judith Anna Nikolić; Ivona Baricević
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

5.  Lack of Association between Pre-Operative Insulin-Like Growth Factor-1 and the Risk of Post-Operative Delirium in Elderly Chinese Patients.

Authors:  Che-Sheng Chu; Chih-Kuang Liang; Ming-Yueh Chou; Yu-Te Lin; Chien-Jen Hsu; Chin-Liang Chu; Po-Han Chou
Journal:  Psychiatry Investig       Date:  2016-05-18       Impact factor: 2.505

6.  Safety and Feasibility Assessment of Repetitive Vascular Occlusion Stimulus (RVOS) Application to Multi-Organ Failure Critically Ill Patients: A Pilot Randomised Controlled Trial.

Authors:  Ismita Chhetri; Julie E A Hunt; Jeewaka R Mendis; Lui G Forni; Justin Kirk-Bayley; Ian White; Jonathan Cooper; Karthik Somasundaram; Nikunj Shah; Stephen D Patterson; Zudin A Puthucheary; Hugh E Montgomery; Benedict C Creagh-Brown
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

Review 7.  Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Authors:  Weronika Wasyluk; Martyna Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

8.  Parenteral versus enteral nutrition: effect on serum cytokines and the hepatic expression of mRNA of suppressor of cytokine signaling proteins, insulin-like growth factor-1 and the growth hormone receptor in rodent sepsis.

Authors:  Michael J O'Leary; Aiqun Xue; Christopher J Scarlett; Andre Sevette; Anthony J Kee; Ross C Smith
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 9.  Sepsis therapies: learning from 30 years of failure of translational research to propose new leads.

Authors:  Jean-Marc Cavaillon; Mervyn Singer; Tomasz Skirecki
Journal:  EMBO Mol Med       Date:  2020-03-16       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.